Results 151 to 160 of about 46,962 (257)

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

British Journal of Haematology, Volume 208, Issue 1, Page 39-53, January 2026.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source

Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib [PDF]

, 2011
Melissa L. Johnson, Greg J. Riely, Naiyer A. Rizvi, Christopher G. Azzoli, Mark G. Kris, Camelia S. Sima, Michelle S. Ginsberg, William Pao, Vincent A. Miller   +8 more
openalex   +1 more source

Stem cells in chronic myeloid leukaemia [PDF]

, 2007
Holyoake, T., Pellicano, F.
core   +1 more source

Cellular Senescence, Inflammaging and Cardiovascular Disease

Immunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Aging is the most important yet unmodifiable risk factor for cardiovascular disease (CVD). As a result, targeting cardiovascular aging has emerged as a promising strategy to promote long‐term cardiovascular health. This review summarizes current knowledge on the effects of aging within the cardiovascular system as well as systemic processes ...
Lukas Zanders, Denada Arifaj, Julian U. G. Wagner, Stefanie Dimmeler   +3 more
wiley   +1 more source

Data from A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an ¹⁸[F]-Positron Emitting, Fluorescent Derivative of Dasatinib

, 2023
Melinda Wang, Harikrishna Kommidi, Umberto Tosi, Hua Guo, Zhiping Zhou, Melanie Schweitzer, Linda Y. Wu, Ranjodh Singh, Shengqi Hou, Benedict Law, Richard Ting, Mark M. Souweidane   +11 more
openalex   +1 more source

From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease

Journal of Neurochemistry, Volume 170, Issue 1, January 2026.
During aging, progressive alterations in glial networks reshape intercellular communication within the central nervous system. In the young brain, astrocytes and microglia actively regulate metabolic, immune, and synaptic processes that sustain neural circuit stability.
Lívia de Sá Hayashide, Bruna Pessoa, Gustavo Dias, Bruno Pontes, Rafael Serafim Pinto, Luan Pereira Diniz   +5 more
wiley   +1 more source

Data from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

, 2023
Srivandana Akshintala, R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe, Andrea M. Gross, Joanne Derdak, Haiyan Lei, Alexander Pan, Eva Dombi, Isabel Palacio-Yance, Kailey R. Herrera, Markku Miettinen, Helen X. Chen, Seth M. Steinberg, Lee J. Helman, Leo Mascarenhas, Brigitte C. Widemann, Fariba Navid, Jack F. Shern, Christine M. Heske   +21 more
openalex   +1 more source

Design and Validation of a Predictive Model for Hepatocellular Carcinoma Based on Genes With Differential Expression Driven by DNA Methylation

International Journal of Genomics, Volume 2026, Issue 1, 2026.
Background Hepatocellular carcinoma (HCC) ranks among the world′s most lethal cancers, with the majority of cases diagnosed at advanced stages. Accurate prognostic assessment is therefore essential for HCC management. This study utilized DNA methylation (MDGs) and RNA‐sequencing data to develop and validate a predictive model for HCC.
Geyang Hu, Liang Zhou, Jie Zhang, Pengpeng Zhang   +3 more
wiley   +1 more source

Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib – a retrospective chart review analysis

, 2013
James D. Griffin, Annie Guérin, Lei Chen, Alexander R. Macalalad, Jiayuan Luo, Raluca Ionescu‐Ittu, Eric Q. Wu   +6 more
openalex   +2 more sources

Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells [PDF]

, 2013
Sebastian Halbach, Kristoffer Rigbolt, Franziska U. Wöhrle, Britta Diedrich, Christine Gretzmeier, Tilman Brummer, Jörn Dengjel   +6 more
openalex   +1 more source